Who owns Karyopharm Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of KPTI from SEC Form 13F filings across 92 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 92 institutions disclosed 17.3M shares of Karyopharm Therapeutics Inc. worth $21.1M — about 59.9% of shares outstanding; the largest disclosed holder is ADAGE CAPITAL PARTNERS GP, L.L.C.. Source: SEC Form 13F filings, parsed by EvidInvest.
92
13F holders
$21.1M
value, 2026 filers
59.9%
of shares outstanding (17.3M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of KPTI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.0M | $2.4M | 0.0% | 6.9% | +31.3% |
| 2 | BlackRock, Inc. | 1.5M | $1.9M | 0.0% | 5.3% | +7.3% |
| 3 | ACORN CAPITAL ADVISORS, LLC | 1.2M | $1.5M | 0.4% | 4.2% | -19.5% |
| 4 | Catalio Capital Management, LP | 976,191 | $1.2M | 0.2% | 3.4% | +3.8% |
| 5 | UBS Group AG | 963,891 | $1.2M | 0.0% | 3.3% | +172.6% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 940,813 | $1.1M | 0.0% | 3.3% | -1.9% |
| 7 | AQR CAPITAL MANAGEMENT LLCNEW | 931,658 | $1.1M | 0.0% | 3.2% | new |
| 8 | Avidity Partners Management LP | 884,900 | $1.1M | 0.2% | 3.1% | -4.3% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 617,904 | $752,000 | 0.0% | 2.1% | +106.7% |
| 10 | STRS OHIONEW | 542,500 | $661,850 | 0.0% | 1.9% | new |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 458,521 | $559,558 | 0.0% | 1.6% | -13.7% |
| 12 | MORGAN STANLEY | 385,745 | $470,609 | 0.0% | 1.3% | +90.5% |
| 13 | STATE STREET CORP | 369,341 | $450,596 | 0.0% | 1.3% | +13.3% |
| 14 | Brevan Howard Capital Management LP | 352,637 | $430,217 | 0.0% | 1.2% | +13.8% |
| 15 | ROYAL BANK OF CANADA | 310,728 | $378,000 | 0.0% | 1.1% | +414.2% |
| 16 | Davidson Kempner Capital Management LP | 300,000 | $366,000 | 0.0% | 1% | 0.0% |
| 17 | BANK OF AMERICA CORP /DE/ | 278,982 | $340,358 | 0.0% | 1% | +458.8% |
| 18 | TWO SIGMA INVESTMENTS, LP | 273,870 | $334,121 | 0.0% | 0.9% | -60.6% |
| 19 | Context Capital Management, LLCNEW | 263,696 | $321,709 | 0.0% | 0.9% | new |
| 20 | GOLDMAN SACHS GROUP INC | 256,190 | $312,552 | 0.0% | 0.9% | -82.0% |
| 21 | JPMORGAN CHASE & CO | 250,611 | $301,986 | 0.0% | 0.9% | +20.7% |
| 22 | FMR LLC | 240,312 | $293,181 | 0.0% | 0.8% | +2589.3% |
| 23 | JANE STREET GROUP, LLC | 195,300 | $238,266 | 0.0% | 0.7% | +488.7% |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 191,231 | $233,302 | 0.0% | 0.7% | new |
| 25 | Caption Management, LLCNEW | 185,745 | $226,609 | 0.0% | 0.6% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.